Anxiolytics -
-20% with code BOOKS
Shipping in 12-18 days
30-day return policy
For over thirty years the benzodiazepines monopolised not only the anxiolytic market but also clinical and animal research in anxiety. Indeed many animal tests developed since the 1960s have been optimised for the benzodiazepines and some programmes have even screened candidates as potential anxiolytics on their benzodiazepine-like side-effects rather than their anxiolytic activity. With the realisation of ... Full description
You May Also Like
TOP
The Myth of Normal: Trauma, Illness, and Healing in a Toxic Culture
-20% with code BOOKS
In stock at our supplier
TOP
The Checklist Manifesto: How to Get Things Right
-20% with code BOOKS
In stock at our supplier
TOP
No Bad Parts: Healing Trauma and Restoring Wholeness with the Internal Family Systems Model
-20% with code BOOKS
In stock at our supplier
TOP
On Connection: 'Powerful' MATT HAIG
-20% with code BOOKS
In stock at our supplier
TOP
Oxford Handbook of Clinical Medicine
Peter Hateley, Iain McGurgan, Ian B. Wilkinson, Tim Raine, Dearbhla Kelly, Kate Wiles
-20% with code BOOKS
In stock at our supplier
TOP
Harrison's Principles of Internal Medicine (Vol.1 & Vol.2)
Stephen Hauser, Joseph Loscalzo, Steven Holland, Dan Longo, J. Larry Jameson, Dennis Kasper, Carol Langford, Anthony Fauci
-20% with code BOOKS
In stock at our supplier
TOP
The Body Keeps the Score: Brain, Mind, and Body in the Healing of Trauma
-20% with code BOOKS
In stock at our supplier
TOP
Maybe You Should Talk to Someone: a therapist, her thearapist, and our lives revealed
-20% with code BOOKS
In stock at our supplier
TOP
How Not To Die: Discover the foods scientifically proven to prevent and reverse disease
-20% with code BOOKS
In stock at our supplier
TOP
Lifespan: Why We Age - and Why We Don't Have To
-20% with code BOOKS
In stock at our supplier
TOP
Vademecum Metabolicum: Diagnosis and Treatment of Inborn Errors of Metabolism Forword by William L. Nyhan, San Diego, USA
Johannes Zschocke, Georg F. Hoffmann
-20% with code BOOKS
In stock at our supplier
TOP
Cellular and Molecular Immunology
Sarah Henrickson, Abul K. Abbas, Andrew H. Lichtman, Shiv Pillai
-20% with code BOOKS
In stock at our supplier
TOP
Physics, Pharmacology and Physiology for Anaesthetists: Key Concepts for the FRCA
Matthew E. Cross, Emma V. E. Plunkett
-20% with code BOOKS
In stock at our supplier
TOP
Pocket Guide to Teaching for Clinical Instructors
-20% with code BOOKS
In stock at our supplier
TOP
Oxford Handbook of Critical Care
Andrew Webb, Mervyn Singer, Alice Carter
-20% with code BOOKS
In stock at our supplier
TOP
The Wills Eye Manual: Print + eBook with Multimedia: Office and Emergency Room Diagnosis and Treatment of Eye Disease
-20% with code BOOKS
In stock at our supplier
TOP
Who Deserves Your Love: How to Create Boundaries to Start, Strengthen or End Any Relationship
-20% with code BOOKS
In stock at our supplier
TOP
Vaccinated - dead: Histopathological findings following COVID-19 vaccination
-20% with code BOOKS
In stock at our supplier
Description
For over thirty years the benzodiazepines monopolised not only the anxiolytic market but also clinical and animal research in anxiety. Indeed many animal tests developed since the 1960s have been optimised for the benzodiazepines and some programmes have even screened candidates as potential anxiolytics on their benzodiazepine-like side-effects rather than their anxiolytic activity. With the realisation of the drawbacks of the benzodiazepines, namely their potential for tolerance and dependency, there has been a renewed interest in alternative anxiolytics both from existing drugs such as the tricyclic and monoamine oxidase antidepressants and from newer agents such as buspirone. In addition anxiety is no longer considered to be a unique entity but rather an umbrella term for a series of specific anxiety disorders such as panic disorder without or with agoraphobia, generalised anxiety disorder (GAD), specific phobias, social phobias and post-traumatic stress disorder (PTSD). These new clinical categories have opened another dimension in the therapy of anxiety requiring the optimisation of treatments for different syndromes. This book is a critical review of today's anxiolytics and those that may become the anxiolytics of tomorrow. What is clear is that currently there are few clinically satisfactory alternatives to the benzodiazepines for the treatment of acute anxiety. For chronic anxiety, it is generally agreed that benzodi azepines are not the treatment of first choice. The tricyclic and monoamine oxidase antidepressants, the serotonin reuptake inhibitors and buspirone offer better solutions for chronic anxiety but they are still far from being ideal.
More Information
| Publisher | Birkhäuser Basel |
|---|---|
| Series | Milestones in Drug Therapy |
| Release year | 2012 |
| Cover type | Softcover |
| EAN | 9783034895811 |